NLM Logo

E1-INT MeSH Supplementary Concept Data 2024


MeSH Supplementary
E1-INT
Unique ID
C506657
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C506657
Registry Number
0
Heading Mapped to
*Epidermal Growth Factor
*Gastrins
Frequency
1
Note
an injectable islet neogenesis therapy comprising an epidermal growth factor analog and a gastrin analog, for the treatment of insulin-dependent (type 1) and non-insulin-dependent (type 2) diabetes; Hypoglycemic Agents
Source
Curr Opin Investig Drugs 2005 Oct;6(10):1037-42
Date of Entry
2006/01/04
Revision Date
2006/03/02
E1-INT Preferred
page delivered in 0.004s